Venetoclax and Decitabin Based Conditioning Regimen Followed With Post-HSCT Decitabin Maintenance Therapy in TP53 Mutant AML/MDS Patients
Clinical trial NCT05528354 · UNKNOWN
Trial details
- NCT number
- NCT05528354
- Sponsor
- Zhejiang University
- Status
- UNKNOWN
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-02
- Primary completion
- 2025-12-31
- Enrollment
- 58
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.